Published Sep 6, 2021

Healthy Eating & Eating Disorders - Anorexia, Bulimia, Binging | Huberman Lab Podcast #36

Andrew Huberman delves into the complexities of healthy eating and eating disorders, exploring intermittent fasting, the neural underpinnings of bulimia and anorexia nervosa, and the intricate mechanisms of hunger and satiety.
Episode Highlights
Huberman Lab logo

Popular Clips

Questions from this episode

Episode Highlights

  • Clinical Traits

    Bulimia is characterized by episodes of overeating followed by purging, often through self-induced vomiting or laxative use. explains that bulimics may consume 10 to 30 times their daily caloric intake in a short period, overriding the body's signals of fullness 1. This behavior can lead to severe health issues, including damage to the digestive tract and social isolation due to the shame associated with vomiting 1. Huberman also notes that bulimia is more common in young girls and women, and its rates might be increasing 2.

       

    Neural Circuits

    The neural circuitry of bulimia involves a lack of inhibitory control and heightened impulsivity. Huberman highlights that bulimics often have other impulsive behaviors, such as overindulging in alcohol or being sexually promiscuous 3. This impulsivity is linked to disrupted leptin signaling in the brain, which fails to signal when to stop eating 4. He compares this to driving a car without brakes, where the accelerator is always pushed down, making it difficult for bulimics to control their eating habits 4.

       

    Treatment Options

    Effective treatment strategies for bulimia include deep brain stimulation and pharmacological interventions. Huberman discusses the work of Dr. Casey Halpern, who uses deep brain stimulation to target the nucleus accumbens, a brain area associated with food reward 5. This invasive but promising treatment helps offset the brain activity patterns that make food hyper-rewarding. Additionally, clinical trials are exploring the use of MDMA and psilocybin to rewire the brain's reward pathways, although these treatments are still in the experimental stage 6.

Related Episodes